Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation
Authors
Keywords
-
Journal
ChemMedChem
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-09
DOI
10.1002/cmdc.202000210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, Synthesis, Structure–Activity Relationship Studies, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase
- (2017) Alessio De Simone et al. JOURNAL OF MEDICINAL CHEMISTRY
- The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
- (2017) A H Ashok et al. MOLECULAR PSYCHIATRY
- Innovative approaches to bipolar disorder and its treatment
- (2016) Paul J. Harrison et al. Annals of the New York Academy of Sciences
- Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors
- (2016) Rita Maria Concetta Di Martino et al. JOURNAL OF MEDICINAL CHEMISTRY
- Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment
- (2016) Vivek Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cariprazine for the Treatment of Bipolar Disorder
- (2016) Lillian Jan Findlay et al. PERSPECTIVES IN PSYCHIATRIC CARE
- Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments
- (2015) Giovanni Bottegoni et al. ChemMedChem
- Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase
- (2014) Alessio De Simone et al. CHEMICAL COMMUNICATIONS
- Lessons Learnt from Glycogen Synthase Kinase 3 Inhibitors Development for Alzheimer’s Disease
- (2014) Ana Martinez et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar
- (2013) Seng Chuan Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor
- (2012) Amy Hauck Newman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
- (2011) Jean-Martin Beaulieu Frontiers in Molecular Neuroscience
- Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
- (2010) E. Y. T. Chien et al. SCIENCE
- High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields
- (2009) Simone Sciabola et al. Journal of Chemical Information and Modeling
- The influence of lead discovery strategies on the properties of drug candidates
- (2009) György M. Keserü et al. NATURE REVIEWS DRUG DISCOVERY
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started